CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Ceftazidime

头孢他啶 杂质对照品Ceftazidime Impurities

EP49 个杂质条目49 impurity entries

本页汇总 头孢他啶 的 49 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 49 impurity reference standards of Ceftazidime with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 头孢他啶(Ceftazidime)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studies[Determination of ceftazidime and impurities using high performance liquid chromatography]
    Se pu = Chinese journal of chromatography · 2008 · Jiang E, Hu C  ·  PMID 18438029
  2. 杂质研究Impurity studiesIn silico ADME and Toxicity Prediction of Ceftazidime and Its Impurities
    Frontiers in pharmacology · 2019 · Han Y et al.  ·  PMID 31068821  ·  DOI
  3. 杂质研究Impurity studiesPreanalytical Stability of Piperacillin, Tazobactam, Meropenem, and Ceftazidime in Plasma and Whole Blood Using Liquid Chromatography-Tandem Mass Spectrometry
    Therapeutic drug monitoring · 2019 · Mortensen JS et al.  ·  PMID 31306394  ·  DOI
  4. 分析方法Analytical MethodsDeveloping a Validated HPLC Method for Quantification of Ceftazidime Employing Analytical Quality by Design and Monte Carlo Simulations
    Journal of AOAC International · 2021 · Kaur R et al.  ·  PMID 33528003  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSynthesis of [(2)H6]ceftazidime as a stable isotopically labeled internal standard
    Journal of labelled compounds & radiopharmaceuticals · 2015 · Bian L, Bushby N  ·  PMID 26017617  ·  DOI

头孢他啶 —— 原料药与杂质对照品Ceftazidime — drug substance & impurities

共 50 个条目(含原料药本体)50 items incl. the drug substance
Ceftazidime structure
EP原料药 APIAPI
头孢他啶Ceftazidime
Ceftazidime
CAS No.72558-82-8
Chemical FormulaC22H32N6O12S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 1 (Ceftazidime Pentahydrate EP Impurity A) structure
EPA
头孢他啶杂质1 (头孢他啶五水合物EP杂质A)Ceftazidime Impurity 1 (Ceftazidime Pentahydrate EP Impurity A)
Ceftazidime Impurity 1 (Ceftazidime Pentahydrate EP Impurity A)
CAS No.1000980-60-8
Chemical FormulaC22H22N6O7S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 2 (Ceftazidime Pentahydrate EP Impurity B) structure
EPB
头孢他啶杂质2 (头孢他啶五水合物EP杂质B)Ceftazidime Impurity 2 (Ceftazidime Pentahydrate EP Impurity B)
Ceftazidime Impurity 2 (Ceftazidime Pentahydrate EP Impurity B)
CAS No.97148-38-4
Chemical FormulaC22H22N6O7S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 3 (Ceftazidime Pentahydrate EP Impurity C) structure
EPC
头孢他啶杂质3 (头孢他啶五水合物EP杂质C)Ceftazidime Impurity 3 (Ceftazidime Pentahydrate EP Impurity C)
Ceftazidime Impurity 3 (Ceftazidime Pentahydrate EP Impurity C)
CAS No.3432-88-0
Chemical FormulaC13H13N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 3  Chloride  Hydrochloride (Ceftazidime Pentahydrate EP Impurity C  Chloride  Hydrochloride) structure
EPC
头孢他啶杂质3 氯化物盐酸盐 (头孢他啶五水合物EP杂质C 氯化物盐酸盐)Ceftazidime Impurity 3 Chloride Hydrochloride (Ceftazidime Pentahydrate EP Impurity C Chloride Hydrochloride)
Ceftazidime Impurity 3 Chloride Hydrochloride (Ceftazidime Pentahydrate EP Impurity C Chloride Hydrochloride)
CAS No.96752-43-1
Chemical FormulaC13H14N3O3S+·Cl-·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 5 (Ceftazidime Pentahydrate EP Impurity E) structure
EPE
头孢他啶杂质5 (头孢他啶五水合物EP杂质E)Ceftazidime Impurity 5 (Ceftazidime Pentahydrate EP Impurity E)
Ceftazidime Impurity 5 (Ceftazidime Pentahydrate EP Impurity E)
CAS No.102772-66-7
Chemical FormulaC26H30N6O7S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 6 p-Toluenesulfonate (Ceftazidime Pentahydrate EP Impurity F p-Toluenesulfonate) structure
EPF
头孢他啶杂质6 对甲苯磺酸盐 (头孢他啶五水合物EP杂质F 对甲苯磺酸盐)Ceftazidime Impurity 6 p-Toluenesulfonate (Ceftazidime Pentahydrate EP Impurity F p-Toluenesulfonate)
Ceftazidime Impurity 6 p-Toluenesulfonate (Ceftazidime Pentahydrate EP Impurity F p-Toluenesulfonate)
CAS No.24057-28-1
Chemical FormulaC5H5N·C7H8O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 6 Hydrochloride (Ceftazidime Pentahydrate EP Impurity F Hydrochloride) structure
EPF
头孢他啶杂质6 盐酸盐 (头孢他啶五水合物EP杂质F 盐酸盐)Ceftazidime Impurity 6 Hydrochloride (Ceftazidime Pentahydrate EP Impurity F Hydrochloride)
Ceftazidime Impurity 6 Hydrochloride (Ceftazidime Pentahydrate EP Impurity F Hydrochloride)
CAS No.628-13-7
Chemical FormulaC5H5N·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 7 (Ceftazidime Pentahydrate EP Impurity G) structure
EPG
头孢他啶杂质7 (头孢他啶五水合物EP杂质G)Ceftazidime Impurity 7 (Ceftazidime Pentahydrate EP Impurity G)
Ceftazidime Impurity 7 (Ceftazidime Pentahydrate EP Impurity G)
CAS No.194241-83-3
Chemical FormulaC11H14N4O5S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 8 (Ceftazidime Pentahydrate EP Impurity H) structure
EPH
头孢他啶杂质8 (头孢他啶五水合物EP杂质H)Ceftazidime Impurity 8 (Ceftazidime Pentahydrate EP Impurity H)
Ceftazidime Impurity 8 (Ceftazidime Pentahydrate EP Impurity H)
CAS No.1354396-23-8
Chemical FormulaC23H24N6O7S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 6-d5 (Ceftazidime Pentahydrate EP Impurity F-d5) structure
EPF-D5
头孢他啶杂质6-d5 (头孢他啶五水合物EP杂质F-d5)Ceftazidime Impurity 6-d5 (Ceftazidime Pentahydrate EP Impurity F-d5)
Ceftazidime Impurity 6-d5 (Ceftazidime Pentahydrate EP Impurity F-d5)
CAS No.7291-22-7
Chemical FormulaC5D5N
Purity>95%询价On request
Ceftazidime Avibactam structure
—
头孢他啶 阿维巴坦Ceftazidime Avibactam
Ceftazidime Avibactam
CAS No.1393723-27-7
Chemical FormulaC22H22N6O7S2·C7H11N3O6S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Pentahydrate structure
—
头孢他啶五水合物Ceftazidime Pentahydrate
Ceftazidime Pentahydrate
CAS No.78439-06-2
Chemical FormulaC22H32N6O12S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 4 structure
4
头孢他啶杂质4Ceftazidime Impurity 4
Ceftazidime Impurity 4
CAS No.73547-69-0
Chemical FormulaC45H44N6O7S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 9 structure
9
头孢他啶杂质9Ceftazidime Impurity 9
Ceftazidime Impurity 9
CAS No.2630911-86-1
Chemical FormulaC22H22N6O7S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 12 structure
12
头孢他啶杂质12Ceftazidime Impurity 12
Ceftazidime Impurity 12
CAS No.86299-47-0
Chemical FormulaC13H19N3O5S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 14 structure
14
头孢他啶杂质14Ceftazidime Impurity 14
Ceftazidime Impurity 14
CAS No.149-30-4
Chemical FormulaC7H5NS2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 17 structure
17
头孢他啶杂质17Ceftazidime Impurity 17
Ceftazidime Impurity 17
CAS No.110113-80-9
Chemical FormulaC18H16N6O5S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 18 structure
18
头孢他啶杂质18Ceftazidime Impurity 18
Ceftazidime Impurity 18
CAS No.2295689-53-9
Chemical FormulaC24H25N6O8S2+
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 21 structure
21
头孢他啶杂质21Ceftazidime Impurity 21
Ceftazidime Impurity 21
CAS No.66338-96-3
Chemical FormulaC5H5N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 22 structure
22
头孢他啶杂质22Ceftazidime Impurity 22
Ceftazidime Impurity 22
CAS No.1301254-48-7
Chemical FormulaC22H22N6O8S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 26 structure
26
头孢他啶杂质26Ceftazidime Impurity 26
Ceftazidime Impurity 26
CAS No.184696-69-3
Chemical FormulaC8H8N2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 29 structure
29
头孢他啶杂质29Ceftazidime Impurity 29
Ceftazidime Impurity 29
CAS No.1301254-50-1
Chemical FormulaC17H17N5O7S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 33 structure
33
头孢他啶杂质33Ceftazidime Impurity 33
Ceftazidime Impurity 33
CAS No.50382-11-1
Chemical FormulaC6H8ClNO4
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 34 structure
34
头孢他啶杂质34Ceftazidime Impurity 34
Ceftazidime Impurity 34
CAS No.179258-52-7
Chemical FormulaC17H28N3O8PS
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 35 structure
35
头孢他啶杂质35Ceftazidime Impurity 35
Ceftazidime Impurity 35
CAS No.83654-89-1
Chemical FormulaC8H9IN2O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 44 structure
44
头孢他啶杂质44Ceftazidime Impurity 44
Ceftazidime Impurity 44
CAS No.140-40-9
Chemical FormulaC5H5N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 47 structure
47
头孢他啶杂质47Ceftazidime Impurity 47
Ceftazidime Impurity 47
CAS No.1195571-46-0
Chemical FormulaC14H8N2S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 56 structure
56
头孢他啶杂质56Ceftazidime Impurity 56
Ceftazidime Impurity 56
CAS No.86299-46-9
Chemical FormulaC15H23N3O5S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 57 structure
57
头孢他啶杂质57Ceftazidime Impurity 57
Ceftazidime Impurity 57
CAS No.2647895-25-6
Chemical FormulaC17H16N4O4S3
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 65 structure
65
头孢他啶杂质65Ceftazidime Impurity 65
Ceftazidime Impurity 65
CAS No.752152-44-6
Chemical FormulaC17H19N5O8S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 68 structure
68
头孢他啶杂质68Ceftazidime Impurity 68
Ceftazidime Impurity 68
CAS No.118090-09-8
Chemical FormulaC7H5NS2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 72 structure
72
头孢他啶杂质72Ceftazidime Impurity 72
Ceftazidime Impurity 72
CAS No.137171-77-8
Chemical FormulaC34H42ClN5O10S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 76 structure
76
头孢他啶杂质76Ceftazidime Impurity 76
Ceftazidime Impurity 76
CAS No.137171-80-3
Chemical FormulaC34H42ClN5O11S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 77 structure
77
头孢他啶杂质77Ceftazidime Impurity 77
Ceftazidime Impurity 77
CAS No.217796-42-4
Chemical FormulaC22H22N6O7S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 84 structure
84
头孢他啶杂质84Ceftazidime Impurity 84
Ceftazidime Impurity 84
CAS No.1950566-51-4
Chemical FormulaC16H16Cl2N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 87 structure
87
头孢他啶杂质87Ceftazidime Impurity 87
Ceftazidime Impurity 87
CAS No.47288-83-5
Chemical FormulaC16H18N2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 92 structure
92
头孢他啶杂质92Ceftazidime Impurity 92
Ceftazidime Impurity 92
CAS No.64485-82-1
Chemical FormulaC7H9N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 93 structure
93
头孢他啶杂质93Ceftazidime Impurity 93
Ceftazidime Impurity 93
CAS No.36293-63-7
Chemical FormulaC8H16O3
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 94 structure
94
头孢他啶杂质94Ceftazidime Impurity 94
Ceftazidime Impurity 94
CAS No.118444-09-0
Chemical FormulaC14H23NO6
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 97 structure
97
头孢他啶杂质97Ceftazidime Impurity 97
Ceftazidime Impurity 97
CAS No.110130-88-6
Chemical FormulaC7H7N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 109 Monomer structure
109
头孢他啶杂质109 单体Ceftazidime Impurity 109 Monomer
Ceftazidime Impurity 109 Monomer
CAS No.106773-36-8
Chemical FormulaC16H17ClN2O4S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 110 structure
110
头孢他啶杂质110Ceftazidime Impurity 110
Ceftazidime Impurity 110
CAS No.1929-25-5
Chemical FormulaC19H22N4O6S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 114 structure
114
头孢他啶杂质114Ceftazidime Impurity 114
Ceftazidime Impurity 114
CAS No.89604-92-2
Chemical FormulaC20H22N4O4S3
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 115 structure
115
头孢他啶杂质115Ceftazidime Impurity 115
Ceftazidime Impurity 115
CAS No.687618-87-7
Chemical FormulaC21H27N5O8S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 116 structure
116
头孢他啶杂质116Ceftazidime Impurity 116
Ceftazidime Impurity 116
CAS No.182919-90-0
Chemical FormulaC21H27N5O7S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 123 structure
123
头孢他啶杂质123Ceftazidime Impurity 123
Ceftazidime Impurity 123
CAS No.73101-45-8
Chemical FormulaC17H19N5O7S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 126 structure
126
头孢他啶杂质126Ceftazidime Impurity 126
Ceftazidime Impurity 126
CAS No.73443-60-4
Chemical FormulaC19H21N5O9S2
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 129 (Mixture of E/Z-isomers) structure
129
头孢他啶杂质129 (混合E/Z构型)Ceftazidime Impurity 129 (Mixture of E/Z-isomers)
Ceftazidime Impurity 129 (Mixture of E/Z-isomers)
CAS No.134203-48-8
Chemical FormulaC18H27N3O7S
Purity>95%询价On request
10mg25mg50mg100mg
Ceftazidime Impurity 130 structure
130
头孢他啶杂质130Ceftazidime Impurity 130
Ceftazidime Impurity 130
CAS No.137088-65-4
Chemical FormulaC18H27N3O7S
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

头孢他啶 —— 研究文献与合成路线Ceftazidime — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 头孢他啶 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Ceftazidime. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Ceftazidime degradation rates for predicting stability in a portable infusion-pump reservoir
    van Doorne H, Bernaards J, de Jonge P · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 1996 · 被引 3cited 3
  2. Solving the degradation problem of continuous ceftazidime infusions-the Cooltaz study
    La Vita SL, Liu B, Bryant PA · Antimicrobial agents and chemotherapy · 2026 · 被引 1cited 1
  3. Comparison of ceftazidime degradation in glass bottles and plastic bags under various conditions
    Arsène M, Favetta P, Favier B, et al. · Journal of clinical pharmacy and therapeutics · 2002 · 被引 8cited 8
  4. Ultrasonic assisted SPME coupled with GC and GC-MS using pencil lead as a fiber for monitoring the organic volatile impurities of ceftazidime
    Djozan D, Jouyban A, Norouzi J · Journal of chromatographic science · 2008 · 被引 5cited 5
  5. [Determination of ceftazidime and impurities using high performance liquid chromatography]
    Jiang E, Hu C · Se pu = Chinese journal of chromatography · 2008
  6. Assay of ceftazidime in biological fluids using high-pressure liquid chromatography
    Ayrton J · The Journal of antimicrobial chemotherapy · 1981 · 被引 34cited 34

合成与制备工艺专利Synthesis & process patents

  1. Method for preparing ceftazidime midbody
    YONGJIN WANG, FENGXIA LI, HONGMEI XU · 公开号 CN101293891CN101293891 · 2008
  2. Method for preparing ceftazidime pentahydrate
    YULIN ZHENG, HAIYING GUAN, QING LI · 公开号 CN101607966CN101607966 · 2009
  3. Synthesis method of 7-bata-trityl side-chain acid as intermediate of ceftazidime pentahydrate
    MA HONGMEI XU · 公开号 CN1923823CN1923823 · 2007
  4. Process for preparing ceftazidime pentahydrate
    WIRTH DAVID DALE · 公开号 EP0278656EP0278656 · 1988
  5. Process for the preparation of crystalline ceftazidime pentahydrate
    BROWNING RONALD CLAY, PLEISS MELVIN GALE JR · 公开号 EP0187450EP0187450 · 1986

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

头孢他啶 杂质谱研究要点Ceftazidime — impurity profiling notes

下面这些是拿到 头孢他啶 的 50 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 50 impurity entries for Ceftazidime, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances